Monocytes are an essential cellular component of the innate immune system that support the 33 host's effectiveness to combat a range of infectious pathogens. Hemopoietic cell transplantation (HCT) 34 results in transient monocyte depletion, but the factors that regulate recovery of monocyte populations 35 are not fully understood. In this study, we investigated whether the composition of the gastrointestinal 36 microbiota is associated with the recovery of monocyte homeostasis after HCT. 37 38 Methods:
152
We analyzed obligate anaerobic bacteria by major anaerobic groups defined at various 153 taxonomic levels for their importance in maintaining 'healthy' immunity [35, [43] [44] [45] [46] : Clostridia (class), 154 Bacterioidetes (phylum), Negativicutes (class) and Fusobacteria (genus). Percent anaerobes in a given 155 stool sample was calculated by adding the percent 16S rRNA gene sequences of these obligate 156 anaerobic bacteria.
157 Monocyte subsets, analysis of blood samples, monocyte isolation and flow cytometry 158 A median of 7 blood samples were obtained from each patient during transplant days -10 to 159 +30. 5-10 cc of blood in heparinized tubes were processed within four hours of collection. The first 160 blood sample was collected within two days of hospital admission (prior to any perturbations to white 161 blood cells from chemotherapy or radiation) and subsequent blood samples were collected at the start 162 of white blood cell reconstitution through engraftment [47, 48] . 
179
We analyzed absolute monocyte count recovery as a function of time at the start of immune 180 reconstitution defined as: engraftment day minus 2 days ("reconstitution day") until hospital discharge, 181 using conditioning intensity and transplant type as stratification variables. Linear mixed models were fit 182 using patient as a random effect (for intercept), absolute monocyte count as the dependent variable, 183 and reconstitution day as a fixed effect. Fixed effect sizes and 95% confidence intervals are shown. 
189
We calculated the Pearson correlation coefficient to measure the strength of the relationship 190 between the proportion of anaerobic commensal gut microbes and microbial diversity to monocyte 191 subset recovery. Next, we trained linear regression models while controlling for false discovery rates 192 [52] to assess whether or not different clinical predictors correlated with monocyte recovery in the last 193 blood sample tested (using the above mentioned 'target' values). The following clinical variables were (Figure 2A) . This observation was especially true with respect to 240 the recovery of non-classical monocytes. On average, patients who were recipients of either an auto-241 HCT or allo-HCT with RIC were more likely than allo-HCT patients with MAC to recover classical 242 monocytes to target threshold (85%). The threshold of 5% intermediate monocytes was met in 72% 243 (13/18) of patients, while those that received an allo-HCT with MAC conditioning were more likely to be 244 discharged with levels of circulating non-classical monocytes that met target (10%) ( Figure 2B ).
245
We next compared the frequency of circulating monocytes subsets with the composition of the 246 intestinal microbiota. Diversity of intestinal microbial communities, as measured by inverse Simpson 247 index, were not associated with monocyte recovery ( Figure 3A) . Additionally, the proportion of obligate 248 anaerobes associated with a healthy flora (Negativacutes, Clostridia, Bacteroidiales, and Fusobacteria) 249 within the microbiota did not correlate with monocyte recovery (Figure 3B) .
250
While the proportion of monocyte subset recovery did not correlate with the microbiota, we 251 next sought to investigate whether immune activation status of monocytes subsets was altered by the 252 microbiota composition. Monocyte immune activation phenotype as measured by the expression of cell 253 surface markers (CD86, HLA-DR, and CCR-2 ( Supplementary Table 1) ). was assessed in each three 254 subsets of monocytes. No correlation was observed between expression of these markers and 255 microbiota diversity (Supplementary Figure 3) or percent of obligate anaerobic bacteria in the 256 microbiota (Supplementary Figure 4) .
257
We used a simple linear regression model to test whether different compositional 258 characteristics of the microbiota and different clinical variables are related to monocyte recovery. In a 259 linear regression model, microbiota diversity and the proportion of gram-negative Proteobacteria? in 260 the gut were not observed to be associated with monocyte recovery of each subset. Exposure to GCSF 261 within 7 days of blood sample collection/processing was associated with successful reconstitution of 262 classical and intermediate monocytes (p = 0.037 and p =0.002, respectively). Conversely, a T-cell 263 depleted transplant was negatively associated with these monocyte subsets (p = 0.041 and p = 0.008, 264 respectively) Table 2 . Non-classical monocytes were not associated with any of the clinical predictors we 265 defined. 
281
This pilot study involved high-frequency collection of stool and blood samples from 18 patients 282 to assess whether a link between the microbiota and monocyte recovery could be found. We found no 283 correlation between the microbiota composition and differences in monocyte recovery when analyzing 284 a higher-diversity microbiota or a microbiota composed primarily of either commensal anaerobes or 285 Gram-negative organisms. We also found no association between microbiota composition and the 286 expression of co-stimulatory markers, including CD86, HLA-DR and the chemokine receptor, CCR2.
287
Analysis of factors associated with immune reconstitution revealed that any link between the 288 microbiota and immune reconstitution is weak relative to other clinical variables. As expected, GCSF 289 exposure correlated positively with classical and intermediate monocyte reconstitution, while T cell 290 depletion by means of CD34 positive selection was negatively associated with classical and intermediate 291 monocyte subset reconstitution. We also found significant variability in the reconstitution of absolute 13 292 monocyte counts and monocyte subsets across patients. The biological significance that the varying rate 293 of monocyte recovery has on patient outcomes needs to be further explored.
294
Discerning the effects of many patient variables in the setting of HCT, including medications 295 delivered and clinical complications that ensue (bacteremia, fever, GVHD, etc.) make forming a direct 296 relationship between the microbiota and monocytes in HCT patients challenging [61] . Medications given 297 to HCT patients that have immunomodulating properties (i.e., antibiotics and steroids), could serve as 298 confounders in our analysis. 
303
While we were not able to discern an association between microbiota composition and 304 monocyte recovery in this heterogeneous pilot cohort, this study demonstrates the feasibility of high-305 resolution sampling of blood and stool samples and opens the door to future studies where sampling 306 many more patients with daily frequency may help distinguish which microbial and clinical factors drive 307 HCT patient outcomes. 
